Disturbed XIAP and XAF1 expression balance is an independent prognostic factor in gastric adenocarcinomas
- PMID: 18807090
- DOI: 10.1245/s10434-008-0062-4
Disturbed XIAP and XAF1 expression balance is an independent prognostic factor in gastric adenocarcinomas
Abstract
Background: Dysregulation of apoptosis is a key factor in carcinogenesis and tumor progression. X-linked inhibitor of apoptosis (XIAP) is the most potent member of the inhibitor of apoptosis protein (IAP) family, which directly inhibits apoptosis by binding to caspases. Antagonists of XIAP have recently been identified: second mitochondria-derived activator of caspase/direct IAP-binding protein with low PI (Smac/DIABLO) and XIAP-associated factor 1 (XAF1). However, little research has been conducted on the association between gastric cancer survival and the mechanism of apoptosis involving XIAP and its antagonists, Smac/DIABLO and XAF1.
Methods: XIAP, Smac/DIABLO, and XAF1 expression was analyzed by immunohistochemistry (IHC) in 187 gastric adenocarcinomas. Correlations between XIAP, Smac/DIABLO or XAF1 expression and clinicopathological factors were analyzed. Disease-specific survival after surgery was examined.
Results: Of 187 samples, XIAP was overexpressed in 140, Smac was overexpressed in 117, and XAF1 was overexpressed in 106. Individually, XIAP, Smac, and XAF1 were not significantly associated with disease-specific survival. However, patients showing high expression of XIAP and low expression of XAF1 had significantly poorer survival when compared with other groups (P = 0.024).
Conclusion: The expression balance of XIAP and XAF1 is an independent prognostic factor in gastric adenocarcinoma.
Similar articles
-
Disturbed expression of the apoptosis regulators XIAP, XAF1, and Smac/DIABLO in gastric adenocarcinomas.Diagn Mol Pathol. 2007 Mar;16(1):1-8. doi: 10.1097/01.pdm.0000213471.92925.51. Diagn Mol Pathol. 2007. PMID: 17471152
-
Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.Cancer Res. 2003 Nov 1;63(21):7068-75. Cancer Res. 2003. PMID: 14612497
-
Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.Respirology. 2010 Apr;15(3):501-9. doi: 10.1111/j.1440-1843.2010.01710.x. Epub 2010 Feb 24. Respirology. 2010. PMID: 20210890
-
Role of Smac/DIABLO in cancer progression.J Exp Clin Cancer Res. 2008 Sep 26;27(1):48. doi: 10.1186/1756-9966-27-48. J Exp Clin Cancer Res. 2008. PMID: 18822137 Free PMC article. Review.
-
The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy.Exp Oncol. 2012 Oct;34(3):200-11. Exp Oncol. 2012. PMID: 23070005 Review.
Cited by
-
Elevated XIAP expression alone does not confer chemoresistance.Br J Cancer. 2010 Jun 8;102(12):1717-23. doi: 10.1038/sj.bjc.6605704. Epub 2010 May 18. Br J Cancer. 2010. PMID: 20485285 Free PMC article.
-
Smac/DIABLO expression in human gastrointestinal carcinoma: Association with clinicopathological parameters and survivin expression.Oncol Lett. 2014 Dec;8(6):2581-2586. doi: 10.3892/ol.2014.2598. Epub 2014 Oct 9. Oncol Lett. 2014. PMID: 25364431 Free PMC article.
-
Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.BMC Cancer. 2009 Apr 27;9:125. doi: 10.1186/1471-2407-9-125. BMC Cancer. 2009. PMID: 19397802 Free PMC article.
-
Lack of prognostic significance of survivin in pediatric medulloblastoma.Pathol Oncol Res. 2011 Dec;17(4):899-908. doi: 10.1007/s12253-011-9401-z. Epub 2011 Jun 17. Pathol Oncol Res. 2011. PMID: 21681603
-
XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer.Cancer Sci. 2010 Feb;101(2):559-67. doi: 10.1111/j.1349-7006.2009.01396.x. Epub 2009 Oct 12. Cancer Sci. 2010. PMID: 19922503 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous